TrialAmerican journal of perinatology2026

Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia.

James Bussel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.